Safely2Prosperity Unveils Version 2.0 of Its Revolutionary Pandemic Preparedness & Response Platform
Hon. John Norris JD, MBA
FDA Former #2; 20x Board Member; Executive Chair Safely2Prosperity; formerly managed ~14,000 EEs and ~$6B budget; ~30,000 LinkedIn followers; Former Harvard Life Sci and Mgt Faculty Member; facilitated raising $Billions
Safely2Prosperity Unveils Version 2.0 of Its Revolutionary Pandemic Preparedness & Response Platform Amidst CDC-Announced Increased US and Global Health Threats
Boston, MA, August 24, 2023 – Today marks a significant leap in the health-tech world as Safely2Prosperity (S2P) announces the launch of its next-gen Pandemic Preparedness and Response SaaS platform v2.0. Safely2Prosperity crafted this innovative tool to aid organizations in the US and worldwide in combatting infectious disease spread, with the immediate focus on this fall's CDC-announced harmful "Tripledemic" involving COVID-19, Flu, and RSV.
Dr. John Norris, Founder and Executive Chairman of Safely2Prosperity, previously served as the Principal Deputy Commissioner and COO of the US FDA and is a notable Harvard Faculty member. Norris has a storied career in infectious disease spread risk management, providing an expert background for creating this state-of-the-art platform.
Dr. Haden Land, CEO of Safely2Prosperity and former Senior Executive at Lockheed Martin, brings his vast experience in national defense and security risk management to enhance S2P's offering.
The duo's combined expertise assures users that S2P's solutions fully address the urgent need for tools capable of providing scalable, proactive protections. The platform's timely v2.0 release comes after the CDC also announced a potentially more contagious variant of COVID-19, with the CDC emphasizing the urgency for organizations to prepare themselves aggressively.
In the US, dozens of state and federal agencies and two million businesses (for-profit or not-for-profit) having more than 1,000 employees require an advanced digital "infectious disease spread risk management system" like S2P's.
They need this tool to properly and safely manage their complex situation involving a daily flow of potentially millions of data points for larger companies. Worldwide, there are many millions more such businesses.
Dr. Norris commented on the release, "By blending top-tier technology with advanced safety standards, workplace precautions, analytics, and disease tracking measures, we offer a comprehensive and world-class solution to help protect enterprises and their employees."
To further enhance corporate trust in the platform, esteemed media establishments like Forbes and Empire magazines have published cover articles recognizing Safely2Prosperity's unique, powerful, and highly adaptable approach to pandemic and endemic preparedness and response.
Dr. Land added, "We designed our solutions for decision-makers across various government and industry sectors. We are committed to playing a significant role in safeguarding customer operations and stakeholders from pandemic risks."
Organizations interested in exploring the use of Safely2Prosperity's innovative solutions can request a demo and learn more at Safely2Prosperity.com.
About Safely2Prosperity
Founded in early 2021 by Dr. John Norris and led by CEO Dr. Haden Land, Safely2Prosperity is a world-class health-tech company. With its cutting-edge digital Pandemic Preparedness and Response Risk Management system, S2P emphasizes enterprise-wide wellness and user-centric solutions. More information about Safely2Prosperity can be found at Safely2Prosperity.com.
? 2023 Safely2Prosperity LLC and Dr. John Norris, JD, MBA. All rights reserved.
?
CSO of MaaS Health Systems LLC dba MaaS Nanofilms and Trillium Ferroics
1 年CDC desperately needs to open mouth and remove foot, on it's imaginary and paranoid ravings about the non-measurable quantity called the MME (for "Milligram Morphine Equivalent") and the sheer speculation that some number of MME daily triggers addiction. This hysteria has stripped clinicians of their principal palliative care tool for upper respiratory infection, cough suppressants. Reducing the severity of coughs was, for two centuries, the leading means of helping people recover from flu, RSV and other incurable viruses. Seeking to push sales of highly-addictive and rather ineffective Suboxone, the Invidior Corporation has shamelessly promoted the fraudulent pseudo-unit called the MME and has lobbied 36 states into legislating this pseudoscience into effect. Every upper respiratory virus is now life threatening. Shockingly, Invidior's record $290 million antitrust fine for falsely stating that all generic Suboxone pills were dangerous and should be replaced by their newly-patented chewable Suboxone, was just negotiated down 63% and settled. DOJ and CDC are sending the wrong message to the public, that corporate corruption will be winked at, and profitable lies treated by CDC as fact. We must protect ourselves as CDC does not.